Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Sol-Gel Technologies Ltd. (SLGL)

$81.96 +1.75% NASDAQ: SLGL · 15-min delayed
  • Public · NASDAQ: SLGL
  • 28 employees
$254.9MMarket cap
$19.4MRevenue · FY2025
-$6.1MNet income
28Employees
SLGLNASDAQ
2018IPO

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$19.4M
Net income
-$6.1M
Total assets
$29.9M
Market cap
$254.9M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: SLGL
$81.96 +1.75%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$7.01 $97.97

52-week range

Market cap
$254.9M
Shares outstanding
3.1M
Open
Day range
Prev close
Volume
IPO date
Feb 1, 2018

Sol-Gel Technologies Ltd. (SLGL) Stock Price

  • Reported a net loss of $6.1M in FY2025.
  • Trading 16% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Sol-Gel Technologies Ltd..

Write a review
Newsroom

News about Sol-Gel Technologies Ltd.

News & sentiment via Polygon.io

FAQ

Sol-Gel Technologies Ltd.: frequently asked questions

Is Sol-Gel Technologies Ltd. an American company?

Sol-Gel Technologies Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Sol-Gel Technologies Ltd. publicly traded?

Yes — Sol-Gel Technologies Ltd. is a publicly traded company. Its stock trades under the ticker symbol SLGL on the NASDAQ.

What does Sol-Gel Technologies Ltd. do?

Sol-Gel Technologies Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →